(Q36796882)

16 August 2017

1 reference

title

Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy (English)

1 reference

16 August 2017

1 reference

Mahaley MS Jr

1

1 reference

16 August 2017

publication date

1 October 1991

1 reference

Journal of Neuro-Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

11

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

85-147

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02390173

16 August 2017

exact match

0 references

cites work

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Glioblastoma multiforme. An analysis of the results of postoperative radiotherapy alone versus radiotherapy and concomitant 5-fluorouracil. (A prospective randomized study of 32 cases)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Misonidazole combined with hyperfractionation in the management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Fast neutron beam radiotherapy of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Failure of accelerated neutron therapy to control high grade astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02390173

Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy

21 January 2018

1 reference

12 December 2020

Single agent therapy of interferon for brain tumours: Correlation between natural killer activity and clinical course

1 reference

12 December 2020

Radiotherapy and L-triiodothyronine in the treatment of high-grade astrocytoma.

1 reference

12 December 2020

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme

1 reference

12 December 2020

The interaction of drug and radiation effects on normal tissues

1 reference

12 December 2020

Preliminary clinical trial of immunotherapy for malignant glioma

1 reference

12 December 2020

Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.

1 reference

12 December 2020

A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors

1 reference

12 December 2020

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

12 December 2020

A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma

1 reference

12 December 2020

Long-term survivors of high-grade malignant astrocytomas.

1 reference

12 December 2020

A simplification in the use of the NSD concept in practical radiotherapy.

1 reference

12 December 2020

Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma

1 reference

12 December 2020

Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms

1 reference

12 December 2020

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

1 reference

12 December 2020

Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.

1 reference

12 December 2020

Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial.

1 reference

12 December 2020

Photoradiation therapy: current status and applications in the treatment of brain tumors

1 reference

12 December 2020

High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.

1 reference

12 December 2020

Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas

1 reference

12 December 2020

Vincristine therapy in malignant glioma recurrencies.

1 reference

12 December 2020

Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model

1 reference

12 December 2020

Phosphorus-32 therapy of cystic Grade IV astrocytomas: technique and preliminary application.

1 reference

12 December 2020

Intra-arterial cisplatin for the treatment of malignant gliomas.

1 reference

12 December 2020

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study

1 reference

12 December 2020

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

12 December 2020

Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.

1 reference

12 December 2020

High-dose chemotherapy with autologous bone marrow transplantation for malignant brain tumors

1 reference

12 December 2020

High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.

1 reference

12 December 2020

Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma

1 reference

12 December 2020

Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.

1 reference

12 December 2020

Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources

1 reference

12 December 2020

Intra-arterial chemotherapy by cisplatin and cytarabine after temporary disruption of the blood-brain barrier for the treatment of malignant gliomas in adults

1 reference

12 December 2020

Intra-arterial ACNU therapy for malignant brain tumors. Experimental studies and preliminary clinical results

1 reference

12 December 2020

Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.

1 reference

12 December 2020

Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue.

1 reference

12 December 2020

Combined intraarterial and systemic chemotherapy for intracerebral tumors

1 reference

12 December 2020

Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy

1 reference

12 December 2020

High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system

1 reference

12 December 2020

INTRA-ARTERIAL VINCRISTINE THERAPY OF PRIMARY GLIOMAS

1 reference

12 December 2020

Treatment of malignant brain tumors by local methotrexate. A preliminary report.

1 reference

12 December 2020

Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.

1 reference

12 December 2020

Systemic beta-interferon therapy for recurrent gliomas: a brief report.

1 reference

12 December 2020

Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas

1 reference

12 December 2020

Immunohistochemistry of human malignant astrocytoma cells xenografted to rat brain: apolipoprotein E.

1 reference

12 December 2020

Current status of interferon therapy on malignant brain tumor

1 reference

12 December 2020

Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University

1 reference

12 December 2020

BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors

1 reference

12 December 2020

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

12 December 2020

Intratumoural injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma.

1 reference

12 December 2020

Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.

1 reference

12 December 2020

Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

1 reference

12 December 2020

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

1 reference

12 December 2020

Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.

1 reference

12 December 2020

Immunological and biochemical strategies for the identification of brain tumor-associated antigens

1 reference

12 December 2020

Synchronous and metachronous malignant gliomas: CT findings.

1 reference

12 December 2020

Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail

1 reference

12 December 2020

Patterns of failure in intracranial astrocytomas after irradiation: analysis of dose and field factors

1 reference

12 December 2020

Epidemiology of brain tumors: the national survey of intracranial neoplasms

1 reference

12 December 2020

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 reference

12 December 2020

[Analysis of the results of combined treatment of poorly differentiated brain gliomas].

1 reference

12 December 2020

Treatment of intracranial gliomas and metastatic carcinomas by local application of cytostatic agents.

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.

1 reference

12 December 2020

Phase II trial of prednimustine in glioblastoma multiforme

1 reference

12 December 2020

Treatment of brain giomas with high dose of CCNU and autologous bone marrow transplantation.

1 reference

12 December 2020

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of pr

1 reference

12 December 2020

Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study

1 reference

12 December 2020

Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system

1 reference

12 December 2020

Localisation of malignant glioma by a radiolabelled human monoclonal antibody

1 reference

12 December 2020

Intraoperative radiotherapy: the Japanese experience

1 reference

12 December 2020

Computer-assisted stereotactic microsurgery for the treatment of intracranial neoplasms

1 reference

12 December 2020

Photodynamic therapy of malignant brain tumours: a phase I/II trial

1 reference

12 December 2020

Autologous bone-marrow transplantation: host effects of high-dose BCNU

1 reference

12 December 2020

Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study

1 reference

12 December 2020

Misonidazole and irradiation in the treatment of high-grade astrocytomas: Further report of the Vienna study group

1 reference

12 December 2020

Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres

1 reference

12 December 2020

VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.

1 reference

12 December 2020

Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.

1 reference

12 December 2020

Observations on patients with cerebral astrocytoma (glioblastoma multiforme) treated by irradiation under whole-body hypothermia

1 reference

12 December 2020

Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits

1 reference

12 December 2020

Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings.

1 reference

12 December 2020

A phase I study of mixed (neutron and photon) irradiation using two fractions per day in the treatment of high-grade astrocytomas

1 reference

12 December 2020

Treatment of cystic astrocytomas with intracavitary phosphorus 32

1 reference

12 December 2020

Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report

1 reference

12 December 2020

Chemotherapy for malignant gliomas

1 reference

12 December 2020

Treatment experience. Glioblastoma multiforme treated with 15 MeV fast neutrons

1 reference

12 December 2020

Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery

1 reference

12 December 2020

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

12 December 2020

Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas

1 reference

12 December 2020

Immunobiology of human gliomas

1 reference

12 December 2020

A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study

1 reference

12 December 2020

Therapeutic application of radiolabelled monoclonal antibody UJ13A in children with disseminated neuroblastoma--a phase 1 study

1 reference

12 December 2020

Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy

1 reference

12 December 2020

Treatment of malignant cerebral astrocytomas by intra-arterial infusion of vinblastine.

1 reference

12 December 2020

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

12 December 2020

Intraneoplastic Administration of Bleomycin in Intracerebral Gliomas: A Pilot Study

1 reference

12 December 2020

Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in malignant astrocytomas

1 reference

12 December 2020

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

12 December 2020

Intracarotid VP-16 in malignant brain tumors

1 reference

12 December 2020

Controlled study of CCNU and radiation therapy in malignant astrocytoma

1 reference

12 December 2020

Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.

1 reference

12 December 2020

The treatment of glioblastoma multiforme of the brain.

1 reference

12 December 2020

Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.

1 reference

12 December 2020

A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas

1 reference

12 December 2020

Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.

1 reference

12 December 2020

Endocurietherapy of glioblastoma multiforme with 125iodine: results of treatment.

1 reference

12 December 2020

Destruction of small Intracranial Tumours with 60 Co Gamma Radiation Physical and Technical Considerations

1 reference

12 December 2020

Evaluation of fludarabine phosphate in patients with recurrent glioma.

1 reference

12 December 2020

Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas

1 reference

12 December 2020

Investigative protocols to treat malignant brain tumors in North America

1 reference

12 December 2020

Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors—A preliminary report

1 reference

12 December 2020

[A study on the direct antitumoral effect of interferon-alpha on human glioma]

1 reference

12 December 2020

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

1 reference

12 December 2020

Results of combined treatment (by surgery, ionizing radiation and the cytostatic drug CCNU) of patients with anaplastic glial neoplasms of the brain

1 reference

12 December 2020

Superfractionated radiotherapy in grade III, IV intracranial gliomas

1 reference

12 December 2020

Treatment of a brain tumor with BCG cell wall preparation.

1 reference

12 December 2020

Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group

1 reference

12 December 2020

A new method of treatment of inoperable brain tumours by stereotaxic implantation of radioactive gold; a preliminary report.

1 reference

12 December 2020

BCNU solubility and toxicity in the treatment of malignant astrocytomas.

1 reference

12 December 2020

Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study

1 reference

12 December 2020

Randomized controlled study of the effect of adjuvant immunotherapy with Picibanil on 51 malignant gliomas.

1 reference

12 December 2020

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

1 reference

12 December 2020

Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms.

1 reference

12 December 2020

Treatment of patients with recurrent primary brain tumors with AZQ.

1 reference

12 December 2020

Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources

1 reference

12 December 2020

Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas.

1 reference

12 December 2020

Analysis and interpretation of response rates for anticancer drugs

1 reference

12 December 2020

Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme

1 reference

12 December 2020

Phase II trial of mitogauzone in malignant primary brain tumors

1 reference

12 December 2020

Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma

1 reference

12 December 2020

Supraophthalmic carotid infusion for brain chemotherapy. Experience with a new single-lumen catheter and maneuverable tip.

1 reference

12 December 2020

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

12 December 2020

The design of cytotoxic-agent-antibody conjugates

1 reference

12 December 2020

Phase II trial of interferon-beta for treatment of recurrent glioblastoma multiforme.

1 reference

12 December 2020

Local administration of interferon for malignant brain tumors.

1 reference

12 December 2020

National survey of patterns of care for brain-tumor patients

1 reference

12 December 2020

[Interferon therapy for malignant brain tumors-present and future (author's transl)]

1 reference

12 December 2020

Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group

1 reference

12 December 2020

Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors

1 reference

12 December 2020

"Eight-drugs-in-one-day" chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas

1 reference

12 December 2020

Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection

1 reference

12 December 2020

Phase II evaluation of anguidine in central nervous system tumors: a southwest Oncology Group study.

1 reference

12 December 2020

The fallacy of the localized supratentorial malignant glioma

1 reference

12 December 2020

Intravenous BCNU and AZQ in patients with recurrent malignant gliomas

1 reference

12 December 2020

Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.

1 reference

12 December 2020

Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)

1 reference

12 December 2020

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

1 reference

12 December 2020

High-dose radiation therapy with low-dose (pulsed) BCNU in malignant gliomas: An eastern cooperative oncology group (ECOG) report

1 reference

12 December 2020

Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients

1 reference

12 December 2020

Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.

1 reference

12 December 2020

Radiation therapy in the treatment of cerebral astrocytoma

1 reference

12 December 2020

Interstitial irradiation of brain tumors: a review

1 reference

12 December 2020

Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells. Case report

1 reference

12 December 2020

Effect of human leukocyte interferon on malignant brain tumors.

1 reference

12 December 2020

Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.

1 reference

12 December 2020

Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors

1 reference

12 December 2020

Cisplatin plus cytosine arabinoside in adults with malignant gliomas

1 reference

12 December 2020

Direct delivery of medication into a brain tumor through multiple chronically implanted catheters.

1 reference

12 December 2020

Brain tumor chemotherapy with mithramycin and vincristine.

1 reference

12 December 2020

New Implantable Continuous Administration and Bolus Dose Intracarotid Drug Delivery System for the Treatment of Malignant Gliomas

1 reference

12 December 2020

Interleukin-2 and lymphokine activated killer (LAK) cells in the treatment of malignant glioma: clinical and experimental studies

1 reference

12 December 2020

[Immunotherapy for malignant gliomas (author's transl)]

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Autologous glioma transplantation.

1 reference

12 December 2020

Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas

1 reference

12 December 2020

Intrathecal injection of autologous leucocytes in glioblastoma: circulatory dynamics within the subarachnoid space and clinical results

1 reference

12 December 2020

Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.

1 reference

12 December 2020

Experimental tumoricidal effects of monoclonal antibody against solid breast tumors

1 reference

12 December 2020

Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation

1 reference

12 December 2020

Stereotactic endocavitary treatment of cysts and pseudocysts of glioma. Preliminary report.

1 reference

12 December 2020

Comparison of postoperative irradiation alone and in combination with BCNU (NSC-409962) in the management of malignant gliomas.

1 reference

12 December 2020

In vivo immunization against autologous glioblastoma-associated antigens

1 reference

12 December 2020

Interstitial microwave hyperthermia for brain tumors. Results of a phase-1 clinical trial.

1 reference

12 December 2020

Treatment of malignant recurrent glioma by intra-arterial, infra-ophthalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea. A phase II study.

1 reference

12 December 2020

Large dose fraction radiotherapy in the treatment of glioblastoma.

1 reference

12 December 2020

Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Part I: Analysis of results

1 reference

12 December 2020

Effects of ACNU and radiotherapy on malignant glioma

1 reference

12 December 2020

Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy.

1 reference

12 December 2020

[Active immunotherapy of cerebral tumor. 20 cases]

1 reference

12 December 2020

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma

1 reference

12 December 2020

High dose radiation therapy in the treatment of malignant gliomas: Final Report

1 reference

12 December 2020

Clinical experience and expectations with helium and heavy ion irradiation

1 reference

12 December 2020

A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors

1 reference

12 December 2020

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

1 reference

12 December 2020

Treatment of grade III and IV astrocytoma with high-dose irradiation: schedule and chemotherapy

1 reference

12 December 2020

Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

1 reference

12 December 2020

Preliminary observations on the use of Corynebacterium parvum in patients with primary intracranial tumors: effect on intracranial pressure

1 reference

12 December 2020

Effects of intracarotid administration of nitrogen mustard on normal brain and brain tumors.

1 reference

12 December 2020

Specific chromosomal abnormalities in malignant human gliomas

1 reference

12 December 2020

Fast neutron therapy for advanced brain tumors

1 reference

12 December 2020

Post operative radiation therapy in the management of brain astrocytomata-retrospective study of 142 patients.

1 reference

12 December 2020

Mithramycin (NSC-24559) therapy for primary glioblastomas.

1 reference

12 December 2020

Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas

1 reference

12 December 2020

Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU

1 reference

12 December 2020

[Treatment of malignant glioma with mumps virus (author's transl)]

1 reference

12 December 2020

Chemotherapy of brain cancer: experimental and clinical studies in localized hypothermic cerebral perfusion.

1 reference

12 December 2020

Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A.

1 reference

12 December 2020

Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds

1 reference

12 December 2020

Treatment of small cerebral gliomas with CT-aided stereotaxic curietherapy

1 reference

12 December 2020

A phase II trial of oral melphalan in recurrent primary brain tumors.

1 reference

12 December 2020

Simultaneous radio- and chemotherapy of inoperable brain tumours.

1 reference

12 December 2020

Anaplastic astrocytoma and glioblastoma: pion irradiation with the dynamic conformation technique at the Swiss Institute for Nuclear Research (SIN).

1 reference

12 December 2020

Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study

1 reference

12 December 2020

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

1 reference

12 December 2020

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

12 December 2020

Intracarotid cisplatin chemotherapy for recurrent gliomas

1 reference

12 December 2020

Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.

1 reference

12 December 2020

Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches

1 reference

12 December 2020

Lonidamine in primary malignant brain tumors. Preliminary report.

1 reference

12 December 2020

Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens

1 reference

12 December 2020

Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukin-2.

1 reference

12 December 2020

Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.

1 reference

12 December 2020

Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.

1 reference

12 December 2020

Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine).

1 reference

12 December 2020

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

1 reference

12 December 2020

Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme

1 reference

12 December 2020

Results of intermittent, prolonged infusion of nitrogen mustard into the carotid artery in twelve patients with cerebral gliomas.

1 reference

12 December 2020

Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma—First evaluation

1 reference

12 December 2020

Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma

1 reference

12 December 2020

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

12 December 2020

Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report

1 reference

12 December 2020

Effect of human fibroblast interferon on malignant brain tumors

1 reference

12 December 2020

Isolated perfusion in treatment of advanced carcinoma. Brain and face tumors.

1 reference

12 December 2020

Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.

1 reference

12 December 2020

Photoradiation therapy and its potential in the management of neurological tumors

1 reference

12 December 2020

Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Radiation therapy for neoplasms of the brain

1 reference

12 December 2020

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

12 December 2020

High-dose methotrexate in malignant gliomas

1 reference

12 December 2020

Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.

1 reference

12 December 2020

A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.

1 reference

12 December 2020

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

12 December 2020

The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme

1 reference

12 December 2020

Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia

1 reference

12 December 2020

Clinical effect of interferon in malignant brain tumours.

1 reference

12 December 2020

Phase II evaluation of thioTEPA for treatment of central nervous system tumors

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.

1 reference

12 December 2020

Phase II study of trimetrexate in recurrent anaplastic glioma. National Cancer Institute of Canada Clinical Trials Group Study.

1 reference

12 December 2020

Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas

1 reference

12 December 2020

Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme

1 reference

12 December 2020

BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors

1 reference

12 December 2020

A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas

1 reference

12 December 2020

Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study

1 reference

12 December 2020

Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.

1 reference

12 December 2020

Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors

1 reference

12 December 2020

CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme

1 reference

12 December 2020

Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system

1 reference

12 December 2020

Antiviral and Antiproliferative Effects of Interferons Delivered via Monoclonal Antibodies

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study.

1 reference

12 December 2020

Neutron interstitial brachytherapy for malignant gliomas: a pilot study

1 reference

12 December 2020

Stereotactic interstitial brachytherapy of malignant astrocytomas with remarks on postimplantation computed tomographic appearance

1 reference

12 December 2020

Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine

1 reference

12 December 2020

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

12 December 2020

Phase II trial of spirogermanium and vindesine in malignant glioma.

1 reference

12 December 2020

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

1 reference

12 December 2020

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report

1 reference

12 December 2020

Proliferative activity and radiosensitivity of human tumors

1 reference

12 December 2020

The preparation and cytotoxic properties of antibody-toxin conjugates

1 reference

12 December 2020

Glioblastoma multiforme: Treatment with radiation and trhodothyronine

1 reference

12 December 2020

Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.

1 reference

12 December 2020

Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

1 reference

12 December 2020

Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.

1 reference

12 December 2020

Effect of DDMP (2, 4-diamino-5-3', 4'-dichlorophenyl-6-methylpyrimidine) on brain gliomas--a phase II study. E.O.R.T.C. Brain Tumor Group

1 reference

12 December 2020

Immunological studies of human gliomas.

1 reference

12 December 2020

Drug streaming during intra-arterial chemotherapy

1 reference

12 December 2020

Carcino-fetal antigen in glial tumours.

1 reference

12 December 2020

Permanent and removable implants for the brachytherapy of brain tumors.

1 reference

12 December 2020

The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine

1 reference

12 December 2020

Mixing studies during intracarotid artery infusions in an in vitro model

1 reference

12 December 2020

Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study

1 reference

12 December 2020

Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.

1 reference

12 December 2020

Glioblastoma multiforme: Treatment by large dose fraction irradiation and metronidazole

1 reference

12 December 2020

Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.

1 reference

12 December 2020

Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies

1 reference

12 December 2020

Fast neutron radiation therapy for glioblastoma multiforme. Results of an RTOG study.

1 reference

12 December 2020

VM-26 as a second drug in the treatment of brain gliomas

1 reference

12 December 2020

Phase I study of aziridinylbenzoquinone (NSC 182986).

1 reference

12 December 2020

Evaluation of mithramycin in the treatment of anaplastic gliomas

1 reference

12 December 2020

Stability and compatibility of antitumor agents in glass and plastic containers

1 reference

12 December 2020

Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study

1 reference

12 December 2020

The treatment of glioblastomas with radium.

1 reference

12 December 2020

Eight-drugs-in-one-day chemotherapy in postirradiated adult patients with malignant gliomas.

1 reference

12 December 2020

Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications

1 reference

12 December 2020

131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?

1 reference

12 December 2020

PCNU treatment for recurrent malignant gliomas.

1 reference

12 December 2020

The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group

1 reference

12 December 2020

Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

1 reference

12 December 2020

Super fractionation in glioblastoma multiforme-results of a phase II study

1 reference

12 December 2020

Superfractionation radiation therapy in the treatment of malignant astrocytoma.

1 reference

12 December 2020

Chemotherapy of brain metastases: current status

1 reference

12 December 2020

Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.

1 reference

12 December 2020

LOCAL CHEMOTHERAPY OF BRAIN TUMORS

1 reference

12 December 2020

Terminology in the description of drug-radiation interactions

1 reference

12 December 2020

Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors.

1 reference

12 December 2020

Treatment of astrocytoma with hydroxyurea and irradiation: report of six patients with 18-month follow-up

1 reference

12 December 2020

Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary bra

1 reference

12 December 2020

Glioblastoma multiforme: pathology, natural history and treatment

1 reference

12 December 2020

[Immunology and immunotherapy of cerebral tumors. Current status]

1 reference

12 December 2020

Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme

1 reference

12 December 2020

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2.

1 reference

12 December 2020

Levamisole in the treatment of glioblastoma multiforme

1 reference

12 December 2020

Hyperthermia and radiation in combination: a clinical fractionation regime

1 reference

12 December 2020

Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates

1 reference

12 December 2020

A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas

1 reference

12 December 2020

Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.

1 reference

12 December 2020

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.

1 reference

12 December 2020

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

1 reference

12 December 2020

A clinical trial of intravenous bleomycin in the treatment of brain tumors

1 reference

12 December 2020

Interstitial hyperthermia and iridium brachytherapy in treatment of malignant glioma. A phase I clinical trial

1 reference

12 December 2020

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1 reference

12 December 2020

Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.

1 reference

12 December 2020

Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.

1 reference

12 December 2020

Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).

1 reference

12 December 2020

Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study

1 reference

12 December 2020

[Intraoperative radiation therapy for malignant glioma]

1 reference

12 December 2020

Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors

1 reference

12 December 2020

Hypoxic Cell Radiosensitizers in the Treatment of Malignant Brain Tumors

1 reference

12 December 2020

Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption.

1 reference

12 December 2020

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441)

1 reference

12 December 2020

A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: a Northern California Oncology Group Study

1 reference

12 December 2020

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

1 reference

12 December 2020

VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.

1 reference

12 December 2020

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

1 reference

12 December 2020

Postoperative intracavitary chemotherapy of malignant gliomas. A preliminary study using methotrexate

1 reference

12 December 2020

Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy

1 reference

12 December 2020

Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord

1 reference

12 December 2020

Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study

1 reference

12 December 2020

Osmotic Blood-Brain Barrier Modification and Combination Chemotherapy: Concurrent Tumor Regression in Areas of Barrier Opening and Progression in Brain Regions Distant to Barrier Opening

1 reference

12 December 2020

Stereotaxic irradiation of brain tumors

1 reference

12 December 2020

Systemic gamma-interferon therapy for recurrent gliomas

1 reference

12 December 2020

Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations

1 reference

12 December 2020

Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

1 reference

12 December 2020

Interferon-beta in patients with low-grade astrocytomas--a phase I study

1 reference

12 December 2020

Fast neutrons and misonidazole for malignant astrocytomas.

1 reference

12 December 2020

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

1 reference

12 December 2020

Salvage immunotherapy of malignant glioma

1 reference

12 December 2020

Treatment of astrocytoma with a 5-day cisplatin infusion

1 reference

12 December 2020

Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma

1 reference

12 December 2020

Neurological surgery, so to speak, out of roentgenology

1 reference

12 December 2020

Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study

1 reference

12 December 2020

Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.

1 reference

12 December 2020

Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor

1 reference

12 December 2020

Theoretic limitations of intracarotid infusions in brain tumor chemotherapy

1 reference

12 December 2020

Report of a randomised pilot study of the treatment of patients with supratentorial gliomas using neutron irradiation

1 reference

12 December 2020

Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02390173

1 reference

16 August 2017

1 reference